Latham & Watkins Assists Siemens Healthineers in Securing CFIUS Clearance

CFIUS determined that there were no unresolved national security issues with respect to Siemens Healthineers’ planned merger with Varian Medical Systems.

November 24, 2020

Siemens Healthineers AG (Frankfurt: SHL), a leading medical technology company headquartered in Erlangen, Germany, has announced that the Committee on Foreign Investment in the United States (CFIUS) concluded its review under Section 721 of the Defense Production Act of 1950, as amended, of the planned merger with Varian Medical Systems, Inc. (Varian, NYSE: VAR) and determined that there were no unresolved national security issues with respect to the transaction.

Latham & Watkins LLP advised Siemens Healthineers on the CFIUS clearance process with a team led by Washington, D.C. partner Les Carnegie and counsel Rachel Alpert, with associate Allison Hugi. The corporate deal team advising on the transaction is led by Orange County and New York partner Charles Ruck, Munich partner Rainer Traugott, and Silicon Valley and New York partner Josh Dubofsky.

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.